Evidence map›Paper›PMID 24332449›Full record

ArticleNeurobiology of aging2014

Reduced excitatory amino acid transporter 1 and metabotropic glutamate receptor 5 expression in the cerebellum of fragile X mental retardation gene 1 premutation carriers with fragile X-associated tremor/ataxia syndrome.

Dalyir I Pretto, Madhur Kumar, Zhengyu Cao, Christopher L Cunningham, Blythe Durbin-Johnson, Lihong Qi, Robert Berman, Stephen C Noctor, Randi J Hagerman, Isaac N Pessah and 1 more

Open access · greenAbstract read
In one paragraph

Article in Neurobiology of aging, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Glial dysregulation in the human brain in fragile X-associated tremor/ataxia syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Metabolic Alterations inFrontiers in molecular biosciences · 2020
    Review
  8. Review
  9. Article
  10. Conditional Knock-out of mGluR5 from Astrocytes during Epilepsy Development Impairs High-Frequency Glutamate Uptake.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Metabotropic glutamate receptor 5 - a promising target in drug development and neuroimaging.European journal of nuclear medicine and molecular imaging · 2016
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Dalyir I PrettoDepartment of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Sacramento, CA, USA; Department of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, CA, USA.
Madhur KumarDepartment of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Sacramento, CA, USA.
Zhengyu CaoDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA.
Christopher L CunninghamDepartment of Psychiatry and Behavioral Sciences, University of California Davis Medical Center, Sacramento, CA, USA.
Blythe Durbin-JohnsonDepartment of Public Health Sciences, University of California Davis, School of Medicine, Davis, CA, USA.
Lihong QiDepartment of Public Health Sciences, University of California Davis, School of Medicine, Davis, CA, USA.
Robert BermanDepartment of Neurological Surgery, School of Medicine, University of California Davis, Davis, CA, USA.
Stephen C NoctorDepartment of Pathology, School of Medicine, University of California Davis, Davis CA, USA; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis School of Medicine, Sacramento, CA, USA.
Randi J HagermanDepartment of Pediatrics, School of Medicine, University of California Davis, Davis CA, USA; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis School of Medicine, Sacramento, CA, USA.
Isaac N PessahDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California Davis, Davis, CA, USA; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis School of Medicine, Sacramento, CA, USA.
Flora TassoneDepartment of Biochemistry and Molecular Medicine, University of California Davis, School of Medicine, Sacramento, CA, USA; Medical Investigation of Neurodevelopmental Disorders (MIND) Institute, University of California Davis School of Medicine, Sacramento, CA, USA. Electronic address: ftassone@ucdavis.edu.
University of California Davis Medical Center · USUniversity of California, Davis · USNeurological Surgery · US

Funding

Restoring FMRP Phenotypes Frpm Temporal Regional and Splice- Isoforms VarationsP30HD002274 · NICHD · UNIVERSITY OF WASHINGTON · PI GURALNICK, MICHAEL J · 1985 to 2013
$33.6M
A Natonal Resource for Postmortem Brain ResearchR24MH068855 · NIMH · MC LEAN HOSPITAL (BELMONT, MA) · PI BENES, FRANCINE M. · 2003 to 2012
$14.8M
GENOTYPE/PHENOTYPE RELATIONSHIPS IN FRAGILE X FAMILIESR01HD036071 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI PAUL J HAGERMAN, RANDI J. HAGERMAN · 1998 to 2026
$13.8M
THE CHARGE STUDY: CHILDHOOD AUTISM RISKS FROM GENETICS AND THE ENVIRONMENT - ADMINISTRATIVE SUPPLEMENTR01ES015359 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HERTZ-PICCIOTTO, IRVA · 2007 to 2019
$13.8M
UC Davis Center for Children's Environmental Health (CCEH)P01ES011269 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI VAN DE WATER, JUDY A. · 2001 to 2018
$12.5M
UC Davis Clinical and Translational Science CenterUL1TR000002 · NCATS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI BERGLUND, LARS F · 2012 to 2015
$12.2M
Expression of the Fragile X GeneR01HD040661 · NICHD · UNIVERSITY OF CALIFORNIA DAVIS · PI HAGERMAN, PAUL J · 2002 to 2016
$4.3M
NCATS NIH HHS UL1 TR000002NICHD NIH HHS HD02274NICHD NIH HHS HD036071NICHD NIH HHS HD040661NICHD NIH HHS N0 1-HD-4-3368NICHD NIH HHS N01-HD-4-3383NICHD NIH HHS P30 HD002274NICHD NIH HHS R01 HD036071NICHD NIH HHS R01 HD040661NIEHS NIH HHS P01 ES011269NIEHS NIH HHS R01 ES 015359NIEHS NIH HHS R01 ES015359NIMH NIH HHS R24 MH068855
6 · The paper itself

Abstract

A premutation (PM) expansion (55-200 CGG) in the fragile X mental retardation gene 1 causes elevated messenger RNA and reduced fragile X mental retardation gene 1 protein. Young PM carriers can develop characteristic physical features and mild cognitive disabilities. In addition, individuals with PM, particularly male carriers, are at high risk to develop fragile X-associated tremor/ataxia syndrome (FXTAS) with aging. Human postmortem FXTAS brains show extensive white matter disease in the cerebellum and the presence of intranuclear inclusions throughout the brain, although their etiologic significance is unknown. In the current work, expression levels of the metabotropic glutamate (Glu) receptor 5 and the Glu transporter excitatory amino acid transporter 1, examined by reverse transcription polymerase chain reaction and western blot analyses, were found to be reduced in the postmortem cerebellum of PM carriers with FXTAS compared with age matched controls, with higher CGG repeat number having greater reductions in both proteins. These data suggests a dysregulation of Glu signaling in PM carriers, which would likely contribute to the development and severity of FXTAS.

Indexed as

Gene ExpressionHeterozygoteMutationAgedAged, 80 and overAgingAtaxiaBrainCerebellumCognitive DysfunctionExcitatory Amino Acid Transporter 1Fragile X Messenger Ribonucleoprotein 1Fragile X SyndromeHumansMaleReceptor, Metabotropic Glutamate 5Excitatory Amino Acid Transporter 1FMR1 protein, humanFragile X Messenger Ribonucleoprotein 1Receptor, Metabotropic Glutamate 5RNA, MessengerEAAT1EAAT2FMR1FMRPFragile X tremor/ataxia syndromeFXTASGlu transportersmGluR5Premutation

Identifiers

PMID24332449
PMCPMC4062976
OpenAlexW2081169395

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.